Endocrine Breast Diseases Clinical Trials in Fuzhou, Fujian

Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study